APA (7th ed.) Citation

Kong, L., Kong, L., Kong, L., Yang, X., Yang, X., Xu, J., & Xu, J. Comparison of safety of lecanemab and aducanumab: A real-world disproportionality analysis using the FDA adverse event reporting system. Frontiers Media S.A.

Chicago Style (17th ed.) Citation

Kong, Lingti, Lingti Kong, Lingti Kong, Xiaohu Yang, Xiaohu Yang, Jian Xu, and Jian Xu. Comparison of Safety of Lecanemab and Aducanumab: A Real-world Disproportionality Analysis Using the FDA Adverse Event Reporting System. Frontiers Media S.A.

MLA (9th ed.) Citation

Kong, Lingti, et al. Comparison of Safety of Lecanemab and Aducanumab: A Real-world Disproportionality Analysis Using the FDA Adverse Event Reporting System. Frontiers Media S.A.